Go offline with the Player FM app!
[The good, the bad, the ugly] Editor's Review week of March 25
Manage episode 410044077 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — FDA approves Akebia Therapeutics' Vafseo anemia drug
The bad — Bristol Myers Squibb's Crohn's disease drug disappoints
The ugly — FDA rejects Regeneron Pharmaceuticals lymphoma treatment
86 episodes
Manage episode 410044077 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — FDA approves Akebia Therapeutics' Vafseo anemia drug
The bad — Bristol Myers Squibb's Crohn's disease drug disappoints
The ugly — FDA rejects Regeneron Pharmaceuticals lymphoma treatment
86 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.